Samsung Biologics and LegoChem enter ADC development deal
Samsung Biologics has entered into a strategic partnership with LegoChem Biosciences to advance ADC programmes aimed at treating solid tumours.
Stay updated with breaking news from Kurma Partner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Samsung Biologics has entered into a strategic partnership with LegoChem Biosciences to advance ADC programmes aimed at treating solid tumours.
Visiongain has published a new report entitled Biological Drug API Manufacturing Services Market Report 2023-2033: Forecasts by Manufacturing Type...
Samsung Biologics said Tuesday it inked a partnership with Kurma Partners, a French venture capital firm specializing in financing health care companies, to offer a variety of drug-related services to Kurma Partners' portfolio companies. Under the partnership, Samsung Biologics will provide biotech companies invested in by Kurma Partners with its customizable chemical, manufacturing and control solutions. Custom...